Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2016 Aug;68(8):1089–1097. doi: 10.1002/acr.22811

Table 2.

Association of knee buckling and knee shifing/slipping at 60 months with falls at 60 months and at 84 months

Baseline exposure/predictor (n) a. Cross-sectional association with falls in the past 12 months at baseline*
Buckling in past 3 months 0 falls 1 fall ≥2 falls
N (%) N (%) OR (95% CI) N (%) OR (95% CI)
0 (1532) 1114 (72.7) 211 (13.8) Ref -- 207 (13.5) Ref --
1+ (310) 175 (56.5) 45 (14.5) 1.25(0.84-1.86) 90 (29.0) 2.00(1.42-2.82)
Shifting /slipping in past 3 months
0 (1296) 975 (73.8) 175 (13.5) Ref -- 164 (12.7) Ref --
1+ (546) 332 (60.8) 81 (14.8) 1.08(0.78-1.50) 133 (24.4) 1.51(1.12-2.03)
Buckling in past 3 months b. Longitudinal association with falls in the past 12 months at 2 year follow-up
0 falls 1 fall ≥2 falls
0 (1427) 1066 (74.7) 190 (13.3) Ref -- 171 (12.0) Ref --
1+ (270) 168 (62.2) 34 (12.6) 1.03(0.66-1.60) 68 (25.2) 1.98(1.35-2.91)
Shifting/slipping in past 3 months
0 (1217) 907 (74.5) 162 (13.3) Ref -- 148 (12.2) Ref --
1+ (480) 327 (68.1) 62 (12.9) 0.92(0.64-1.31) 91 (19.0) 1.10(0.78-1.55)
*

Models include variables for both buckling and shifting/slipping, plus age, gender, race, clinic, BMI, highest K-L grade, history of knee injury causing limited activity, isokinetic knee extension strength (sex-specific tertiles), vibratory perception threshold at the first MTP joint (sex-specific tertiles), foot/ankle pain (number of locations with pain: 0, 1-2, 3-6), hip pain (yes/no), comorbidity index score (0-10), depression (CES-D score >=16 as depression indicator), used prescription narcotic analgesics in past 30 days (yes/no), used prescription sedative-hypnotic medications in the past 30 days (yes/no), knee buckling in the past 12 months but not in the past 30 days (yes/no), sum of WOMAC pain score in both knees.

84 month clinic visit and telephone contact